21 October 2025
CRCM welcomes a new team dedicated to the study of G protein-coupled receptors (GPCRs) […]
1 October 2025
Christophe Ginestier and his team are exploring a new therapeutic strategy to improve the management of relapsed patients.
24 September 2025
Anne-Sophie Chrétien, Frédéric Bard and Brice Chanez - all three recipients of specific "Pancreatic Cancer" funding from the ARC Foundation -.
10 February 2025
We are delighted to welcome Josephine Shabani, a Master 2 student at the University of Verona (Italy), who has recently joined our team.
10 February 2025
This publication in Cell reveals how two distinct E3 ligases target BACH1 quaternary degrons under oxidative stress, in collaboration with several research teams.
28 January 2025
Our research team has nurtured brilliant minds that have contributed to groundbreaking discoveries before embarking on exciting new paths.
28 January 2025
Dr Christophe Ginestier receives a €200,000 Pink Ribbon Award for his project on breast cancer treatment resistance, aimed at identifying new therapies to prevent recurrence.
28 January 2025
The Borg / Maina "Targeting signaling networks and the microenvironment in cancer" team kicks off 2025 by welcoming three Master 2 students. Saliha, Jules and Camille join our ranks!
28 January 2025
Our team recently invested in a D300e digital distributor from TECAN. This acquisition opens up new prospects for high-throughput trials and the identification of innovative treatments.
10 January 2025
Discover Frédéric Bard in the ARC Foundation film, which highlights his commitment and work in cancer research.